As the COVID-19 pandemic unfolded, breast cancer experts realized space in operating rooms and hospitals could become scarce. That meant rethinking standard care, to provide the best way to treat patients under these suddenly restricted conditions. One of the new ideas: Reverse the order of care given to patients with a type of breast cancer…  read on >  read on >

The U.S. Food and Drug Administration plans to expand emergency use of Pfizer’s coronavirus vaccine by next week so that children as young as 12 can be immunized. After Pfizer’s trial in adolescents showed its vaccine worked as well in teens as it does in adults, the FDA started preparing to add an amendment covering…  read on >  read on >

Two widely used COVID-19 vaccines — Pfizer and Moderna — will likely remain powerfully protective against developing serious illness even if coronavirus variants somehow manage to infect vaccinated patients, new research suggests. Both vaccines are based on messenger RNA (mRNA) technology. And investigators say that, at least in theory, such technology can deploy multiple levels…  read on >  read on >

Cancer patients most likely to sign up for clinical trials during their treatment include people of color, those with higher incomes and those who are younger, a new study finds. “This study informs our understanding of who is participating in cancer clinical trials,” said study author Dr. Lincoln Sheets, an assistant research professor at the…  read on >  read on >

You might think everybody knows how to protect themselves from the sun’s harmful rays, but a new survey reveals that one-third of Americans lack a basic understanding of sun safety and skin cancer. That’s the surprising takeaway from an American Academy of Dermatology (AAD) survey of 1,000 U.S. adults. Fifty-three percent of respondents didn’t realize…  read on >  read on >